Base Ten Systems last week completed the sale of a convertiblesubordinated debenture that raised $10 million for the Trenton,NJ, company. Base Ten plans to use proceeds of the issue to funddevelopment and marketing of its Pharmasyst pharmaceutical
Base Ten Systems last week completed the sale of a convertible
subordinated debenture that raised $10 million for the Trenton,
NJ, company. Base Ten plans to use proceeds of the issue to fund
development and marketing of its Pharmasyst pharmaceutical manufacturing
execution system, as well as its uPACS ultrasound miniPACS archiving
product. Base Ten received 510(k) clearance for several uPACS
components in June (SCAN 7/17/96).
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.